Rate My Professor Manjit Kaur

Dr. Kaur's research specializations focus on cancer biomarkers, hemoglobinopathies, and infectious diagnostics. She is Principal Investigator or collaborator on multiple funded projects, including ICMR-supported studies on circulating microRNA-590-5p as a liquid biopsy marker in non-small cell lung cancer, national health research priorities on breast cancer survival, hospital-based cancer registry, and anemia burden in geriatric patients; MoHFW initiatives for haemoglobinopathies and hemophilia screening/treatment; DST projects on long non-coding RNAs in breast and esophageal cancers; and self-funded evaluations of HPV in breast cancer and intraoperative frozen sections. Her key publications include 'Lymphocytic emperipolesis in breast carcinoma on cytology smears' (2023), 'Incidental detection of microsporidium spores on Ziehl-Neelsen stain in Pap smear' (2023), 'Granulomas on cervical Pap smear: “Forget me not”' (2023), 'Bone Marrow Amyloidosis Without Detectable Plasma Cell Dyscrasia' (2025), and 'Schwannoma of Labia Minora' (2025). As Editor-in-Chief of the International Journal of Pathology and Drugs, nodal officer for hemophilia, and organizer of events like the Hands-on FISH Workshop (2023) and World Hemophilia Day observances, she contributes to academic training, research dissemination, and public health initiatives at AIIMS Bathinda.